Effectiveness–implementation hybrid-2 randomised trial of a collaborative Shared Care Model for Detecting Neurodevelopmental Impairments after Critical Illness in Young Children (DAISY): pilot study protocol

• Published in: BMJ open 2022-07, Vol.12 (7), p.e060714
• Main Authors: Long, Debbie, Gibbons, Kristen, Dow, Belinda, Best, James, Webb, Kerri-Lyn, Liley, Helen G, Stocker, Christian, Thoms, Debra, Schlapbach, Luregn J, Wharton, Carolyn, Lister, Paula, Matuschka, Lori, Castillo, Maria Isabel, Tyack, Zephanie, Bora, Samudragupta
• Format: Article
• Language: English
• Subjects: Australia; Child, Preschool; Children & youth; Collaboration; Critical Illness - therapy; developmental neurology & neurodisability; Humans; Illnesses; Intensive Care; Intensive Care Units, Pediatric; Neurodevelopmental disorders; paediatric intensive & critical care; Parents; Pediatrics; Pilot Projects; primary care; Randomized Controlled Trials as Topic
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2021-060714

IntroductionIn Australia, while paediatric intensive care unit (PICU) mortality has dropped to 2.2%, one in three survivors experience long-term neurodevelopmental impairment, limiting their life-course opportunities. Unlike other high-risk paediatric populations, standardised routine neurodevelopmental follow-up of PICU survivors is rare, and there is limited knowledge regarding the best methods. The present study intends to pilot a combined multidisciplinary, online screening platform and general practitioner (GP) shared care neurodevelopmental follow-up model to determine feasibility of a larger, future study. We will also assess the difference between neurodevelopmental vulnerability and parental stress in two intervention groups and the impact of child, parent, sociodemographic and illness/treatment risk factors on child and parent outcomes.Methods and analysisSingle-centre randomised effectiveness–implementation (hybrid-2 design) pilot trial for parents of children aged ≥2 months and